Walgreens Stock Stumbles Amid Legal Challenges, Throwing Cold Water on Hopes for a Rebound

1. WBA's Q1 results exceeded expectations, hinting at potential recovery. 2. Analysts maintain cautious ratings: 4 holds, 3 sells, 1 buy. 3. A lawsuit from the DOJ caused WBA shares to drop over 9%. 4. Cost-cutting measures are in place, but challenges persist in retail pharmacy. 5. Regulatory risks are compounded by struggles in the pharmacy business.